Exact Sciences Corporation
EXAS
$103.75
-$0.19-0.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 23.12% | 20.05% | 15.99% | 10.86% | 10.29% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.12% | 20.05% | 15.99% | 10.86% | 10.29% |
| Cost of Revenue | 18.89% | 22.86% | 17.86% | 7.86% | -13.46% |
| Gross Profit | 25.02% | 18.81% | 15.18% | 12.15% | 25.76% |
| SG&A Expenses | 15.84% | 14.50% | 12.05% | 10.39% | 3.03% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.10% | 17.13% | 10.06% | 7.41% | 4.30% |
| Operating Income | -95.10% | 94.55% | 107.86% | 15.46% | 45.89% |
| Income Before Tax | 90.29% | 52.56% | 99.60% | 6.85% | -1,638.86% |
| Income Tax Expenses | 107.66% | 127.35% | -22.90% | -87.60% | -1,765.74% |
| Earnings from Continuing Operations | 90.06% | 48.76% | 92.50% | 8.18% | -1,637.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 90.06% | 48.76% | 92.50% | 8.18% | -1,637.30% |
| EBIT | -95.10% | 94.55% | 107.86% | 15.46% | 45.89% |
| EBITDA | -321.14% | 51.27% | 225.11% | 35.40% | 149.37% |
| EPS Basic | 90.29% | 49.98% | 92.66% | 10.37% | -1,597.82% |
| Normalized Basic EPS | -98.21% | 140.07% | 114.17% | 14.01% | 32.30% |
| EPS Diluted | 90.29% | 49.98% | 92.66% | 10.37% | -1,597.82% |
| Normalized Diluted EPS | -98.21% | 140.07% | 114.17% | 14.01% | 32.30% |
| Average Basic Shares Outstanding | 2.39% | 2.42% | 2.49% | 2.45% | 2.32% |
| Average Diluted Shares Outstanding | 2.39% | 2.42% | 2.49% | 2.45% | 2.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |